top of page
Contact Us
Contact Us

More case studies

Export of expensive comparators from Europe to China with first leg documents and streamlined approach

CSI’s seamless comparator export to China

CSI’s flexible approach to global distribution ensured a large CRO's five-year and three-year studies across a total of 18 countries could proceed without delay

Global Device Distribution

How CSI rescued an oncology trial when a competitor failed to deliver, despite an extremely tight deadline and scarce supply on the market

Rescuing a Global Biotech's Oncology Study with Cetuximab

How CSI has saved a leading global pharmaceutical company €1 million by sourcing pembrolizumab from the market at the best possible price

Delivering €1 million Savings for Pembrolizumab

How CSI supplied large quantities of ruxolitinib to a CRO’s ongoing Phase 3 oncology study involving 14 countries, nine depots and 67 site shipments

Global CRO Oncology Partnership

How the flexibility and initiative of CSI’s Quality team overcame challenges to ensure timely product supply for a partner’s ongoing clinical trial

A Quality Solution to Clinical Trial Supply

How CSI delivered mission impossible: sourcing specific tested batches of an expensive oncology product from several European markets

Oncology Product Batch Hunting

How CSI used its scientific expertise at the protocol stage to provide flexibility in sourcing strategy and ensure high volumes of a single product were supplied on time to multiple countries

Delivering Comparators for a Global Allergy Study

How CSI’s regulatory guidance and robust sourcing solutions ensured the success of a global flu vaccine trial that could not afford to run behind schedule

Sourcing Flu Vaccines for a Global Trial

How CSI’s scientific insight delivered an agile sourcing model and substantial cost savings for a listed biotechnology company’s global trial

Streamlining Biotechnology Supply Chains

How CSI leveraged relationships with multiple manufacturers to urgently supply large quantities of a generic drug to a global Phase 3 trial

Overcoming Drug Shortages

Challenge

CSI was tasked by one of its CRO partners with sourcing 400 packs of aflibercept from the open market within a tight deadline of two-to-three weeks. A strict expiry date for the product was specified by the client, and the challenge was greater than usual as the order was placed during the Christmas period, which meant warehouse closures and delayed response times from suppliers. To make matters more complex, the client requested a change in quantities after the initial order, resulting in split deliveries that risked further extending the timescale.

Solution

Despite these obstacles, CSI successfully leveraged its relationship with a local vendor to secure the required quantity of the specified cancer medication. Effective communication and coordination between CSI, the client, the vendor and CSI’s warehouse were key during the disrupted holiday period and ensured smooth delivery and completion of quality control checks.

Result

The required quantity of aflibercept was successfully delivered to CSI’s warehouse for immediate distribution to hospitals. True to our promise that no patient would be turned away for lack of medication, the oncology product was delivered within the specified timeframe to several hospitals in the United States.

Case Study

Rapid Oncology Study Supply

How CSI leveraged its vendor and warehouse networks to supply aflibercept for a leading CRO’s oncology study within a tight deadline

Challenge

To source 400 packs of aflibercept from the open market for a CRO’s oncology trial – within a tight deadline and during a holiday period

Solution

Effective communication and coordination between CSI, the client, a local vendor and CSI’s warehouse ensured smooth delivery

Result

The required quantity of cancer medication was successfully delivered to CSI’s warehouse for immediate distribution to hospitals

Get in touch with a member of our experienced team today to discuss your clinical trial supply requirements

Contact us 

bottom of page